These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

461 related items for PubMed ID: 22306417

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. Discovery and characterization of non-ATP site inhibitors of the mitogen activated protein (MAP) kinases.
    Comess KM, Sun C, Abad-Zapatero C, Goedken ER, Gum RJ, Borhani DW, Argiriadi M, Groebe DR, Jia Y, Clampit JE, Haasch DL, Smith HT, Wang S, Song D, Coen ML, Cloutier TE, Tang H, Cheng X, Quinn C, Liu B, Xin Z, Liu G, Fry EH, Stoll V, Ng TI, Banach D, Marcotte D, Burns DJ, Calderwood DJ, Hajduk PJ.
    ACS Chem Biol; 2011 Mar 18; 6(3):234-44. PubMed ID: 21090814
    [Abstract] [Full Text] [Related]

  • 6. Novel lead structures for p38 MAP kinase via FieldScreen virtual screening.
    Cheeseright TJ, Holm M, Lehmann F, Luik S, Göttert M, Melville JL, Laufer S.
    J Med Chem; 2009 Jul 23; 52(14):4200-9. PubMed ID: 19489590
    [Abstract] [Full Text] [Related]

  • 7. Reaction-driven de novo design, synthesis and testing of potential type II kinase inhibitors.
    Schneider G, Geppert T, Hartenfeller M, Reisen F, Klenner A, Reutlinger M, Hähnke V, Hiss JA, Zettl H, Keppner S, Spänkuch B, Schneider P.
    Future Med Chem; 2011 Mar 23; 3(4):415-24. PubMed ID: 21452978
    [Abstract] [Full Text] [Related]

  • 8. Computational sampling of a cryptic drug binding site in a protein receptor: explicit solvent molecular dynamics and inhibitor docking to p38 MAP kinase.
    Frembgen-Kesner T, Elcock AH.
    J Mol Biol; 2006 May 26; 359(1):202-14. PubMed ID: 16616932
    [Abstract] [Full Text] [Related]

  • 9. Development of a fluorescent-tagged kinase assay system for the detection and characterization of allosteric kinase inhibitors.
    Simard JR, Getlik M, Grütter C, Pawar V, Wulfert S, Rabiller M, Rauh D.
    J Am Chem Soc; 2009 Sep 23; 131(37):13286-96. PubMed ID: 19572644
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. CoMFA and docking studies on triazolopyridine oxazole derivatives as p38 MAP kinase inhibitors.
    Shashi Nayana MR, Sekhar YN, Siva Kumari N, Mahmood SK, Ravikumar M.
    Eur J Med Chem; 2008 Jun 23; 43(6):1261-9. PubMed ID: 17825954
    [Abstract] [Full Text] [Related]

  • 12. Novel inhibitor discovery through virtual screening against multiple protein conformations generated via ligand-directed modeling: a maternal embryonic leucine zipper kinase example.
    Mahasenan KV, Li C.
    J Chem Inf Model; 2012 May 25; 52(5):1345-55. PubMed ID: 22540736
    [Abstract] [Full Text] [Related]

  • 13. Discovery of a novel class of non-ATP site DFG-out state p38 inhibitors utilizing computationally assisted virtual fragment-based drug design (vFBDD).
    Moffett K, Konteatis Z, Nguyen D, Shetty R, Ludington J, Fujimoto T, Lee KJ, Chai X, Namboodiri H, Karpusas M, Dorsey B, Guarnieri F, Bukhtiyarova M, Springman E, Michelotti E.
    Bioorg Med Chem Lett; 2011 Dec 01; 21(23):7155-65. PubMed ID: 22014550
    [Abstract] [Full Text] [Related]

  • 14. Discovery of tyrosine kinase inhibitors by docking into an inactive kinase conformation generated by molecular dynamics.
    Zhao H, Huang D, Caflisch A.
    ChemMedChem; 2012 Nov 01; 7(11):1983-90. PubMed ID: 22976951
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. Conformational analysis of the DFG-out kinase motif and biochemical profiling of structurally validated type II inhibitors.
    Vijayan RS, He P, Modi V, Duong-Ly KC, Ma H, Peterson JR, Dunbrack RL, Levy RM.
    J Med Chem; 2015 Jan 08; 58(1):466-79. PubMed ID: 25478866
    [Abstract] [Full Text] [Related]

  • 17. Optimization of alpha-ketoamide based p38 inhibitors through modifications to the region that binds to the allosteric site.
    Montalban AG, Boman E, Chang CD, Ceide SC, Dahl R, Dalesandro D, Delaet NG, Erb E, Ernst JT, Gibbs A, Kahl J, Kessler L, Kucharski J, Lum C, Lundström J, Miller S, Nakanishi H, Roberts E, Saiah E, Sullivan R, Urban J, Wang Z, Larson CJ.
    Bioorg Med Chem Lett; 2010 Aug 15; 20(16):4819-24. PubMed ID: 20663667
    [Abstract] [Full Text] [Related]

  • 18. Protein flexibility in ligand docking and virtual screening to protein kinases.
    Cavasotto CN, Abagyan RA.
    J Mol Biol; 2004 Mar 12; 337(1):209-25. PubMed ID: 15001363
    [Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. Identification of novel p38alpha MAP kinase inhibitors using fragment-based lead generation.
    Gill AL, Frederickson M, Cleasby A, Woodhead SJ, Carr MG, Woodhead AJ, Walker MT, Congreve MS, Devine LA, Tisi D, O'Reilly M, Seavers LC, Davis DJ, Curry J, Anthony R, Padova A, Murray CW, Carr RA, Jhoti H.
    J Med Chem; 2005 Jan 27; 48(2):414-26. PubMed ID: 15658855
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 24.